The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The activity of 5′-adenosine monophosphate-activated protein kinase (AMPK) is inversely correlated with the cellular availability of glucose. When glucose levels are low, the glycolytic enzyme aldolase is not bound to fructose-1,6-bisphosphate (FBP) and, instead, signals to activate lysosomal AMPK. Here, we show that blocking FBP binding to aldolase with the small molecule aldometanib selectively activates the lysosomal pool of AMPK and has beneficial metabolic effects in rodents. We identify aldometanib in a screen for aldolase inhibitors and show that it prevents FBP from binding to v-ATPase-associated aldolase and activates lysosomal AMPK, thereby mimicking a cellular state of glucose starvation. In male mice, aldometanib elicits an insulin-independent glucose-lowering effect, without causing hypoglycaemia. Aldometanib also alleviates fatty liver and nonalcoholic steatohepatitis in obese male rodents. Moreover, aldometanib extends lifespan and healthspan in both Caenorhabditis elegans and mice. Taken together, aldometanib mimics and adopts the lysosomal AMPK activation pathway associated with glucose starvation to exert physiological roles, and might have potential as a therapeutic for metabolic disorders in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Scientists rise up against statistical significance
Amrhein, V., Greenland, S., & McShane, B. (2019) · Nature · doi:10.1038/d41586-019-00857-9 · Cited by 2,983
Moving to a World Beyond “ p < 0.05”
Wasserstein, R. L., Schirm, A. L., & Lazar, N. A. (2019) · The American Statistician · doi:10.1080/00031305.2019.1583913 · Cited by 2,976
Research works printed but not linked: 102
- Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. https://doi.org/10.1038/nrm.2017.95 (2017). · DOI · Paper page
- Carling, D., Clarke, P. R., Zammit, V. A. & Hardie, D. G. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur. J. Biochem. 186, 129–136 (1989). · DOI · Paper page
- Oakhill, J. S. et al. beta-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc. Natl Acad. Sci. USA 107, 19237–19241 (2010). · DOI · Paper page
- Gu, X. et al. Deconvoluting AMP-activated protein kinase (AMPK) adenine nucleotide binding and sensing. J. Biol. Chem. 292, 12653–12666 (2017). · DOI
- Zong, Y. et al. Hierarchical activation of compartmentalized pools of AMPK depends on severity of nutrient or energy stress. Cell Res. 29, 460–473 (2019). · DOI · Paper page
- Marques, P. et al. Essential role of glucokinase in the protection of pancreatic beta cells to the glucose energetic status. Cell Death Discov. 5, 138 (2019). · DOI
- Drake, J. C. et al. Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy. Proc. Natl Acad. Sci. USA https://doi.org/10.1073/pnas.2025932118 (2021). · DOI · Paper page
- Schmitt, D. L. et al. Spatial regulation of AMPK signaling revealed by a sensitive kinase activity reporter. Nat. Commun. 13, 3856 (2021). · DOI
- Zhang, C. S. et al. The lysosomal v-ATPase–Ragulator complex Is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 20, 526–540 (2014). · DOI · Paper page
- Zhang, C. S. et al. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature 548, 112–116 (2017). · DOI · Paper page
- Li, M. et al. Transient receptor potential V channels are essential for glucose sensing by aldolase and AMPK. Cell Metab. 30, 508–524 (2019). · DOI · Paper page
- Zhang, Y. L. et al. AMP as a low-energy charge signal autonomously initiates assembly of AXIN–AMPK–LKB1 complex for AMPK activation. Cell Metab. 18, 546–555 (2013). · DOI · Paper page
- Salt, I. P., Johnson, G., Ashcroft, S. J. H. & Hardie, D. G. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem. J. 335, 533–539 (1998). · DOI · Paper page
- Sakamoto, K. et al. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKα2 but not AMPKα1. Am. J. Physiol. Endocrinol. Metab. 290, E780–E788 (2006).
- Liang, J. et al. Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance. Nat. Commun. 6, 7926 (2015). · DOI · Paper page
- Li, Y. et al. AMPK phosphorylates and Inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376–388 (2011). · DOI · Paper page
- Chen, S. et al. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem. J. 409, 449–459 (2008). · DOI · Paper page
- Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132–141 (2011). · DOI · Paper page
- Kim, J. et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152, 290–303 (2013). · DOI · Paper page
- Day, E. A., Ford, R. J. & Steinberg, G. R. AMPK as a therapeutic target for treating metabolic diseases. Trends Endocrinol. Metab. 28, 545–560 (2017). · DOI · Paper page
- Steinberg, G. R. & Carling, D. AMP-activated protein kinase: the current landscape for drug development. Nat. Rev. Drug Discov. 18, 527–551 (2019). · DOI · Paper page
- Olivier, S., Foretz, M. & Viollet, B. Promise and challenges for direct small-molecule AMPK activators. Biochem. Pharmacol. 153, 147–158 (2018). · DOI · Paper page
- Brass, E. P. & Hoppel, C. L. Mitochondria as targets of drug toxicity: lessons from the R118 phase I experience. Clin. Pharmacol. Ther. 98, 464–466 (2015). · DOI
- Low Wang, C. C., Galinkin, J. L. & Hiatt, W. R. Toxicity of a novel therapeutic agent targeting mitochondrial complex I. Clin. Pharmacol. Ther. 98, 551–559 (2015). · DOI
- Kjobsted, R. et al. Intact regulation of the AMPK signaling network in response to exercise and insulin in skeletal muscle of male patients with Type 2 diabetes: illumination of AMPK activation in recovery from exercise. Diabetes 65, 1219–1230 (2016). · DOI · Paper page
- Cool, B. et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403–416 (2006). · DOI · Paper page
- Ford, R. J. et al. Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. Biochemical J. 468, 125–132 (2015). · DOI · Paper page
- Esquejo, R. M. et al. Activation of liver AMPK with PF-06409577 corrects NAFLD and lowers cholesterol in rodent and primate preclinical models. EBioMedicine 31, 122–132 (2018). · DOI · Paper page
- Gluais-Dagorn, P. et al. Direct AMPK activation corrects NASH in rodents through metabolic effects and direct action on inflammation and fibrogenesis. Hepatol Commun. https://doi.org/10.1002/hep4.1799 (2021). · DOI · Paper page
- Morris, A. J. & Tolan, D. R. Site-directed mutagenesis identifies aspartate 33 as a previously unidentified critical residue in the catalytic mechanism of rabbit aldolase A. J. Biol. Chem. 268, 1095–1100 (1993). · DOI
- Halgren, T. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750–1759 (2004). · DOI · Paper page
- Friesner, R. A. et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 49, 6177–6196 (2006). · DOI · Paper page
- St-Jean, M., Lafrance-Vanasse, J., Liotard, B. & Sygusch, J. High-resolution reaction intermediates of rabbit muscle fructose-1,6-bisphosphate aldolase: substrate cleavage and induced fit. J. Biol. Chem. 280, 27262–27270 (2005). · doi:10.1074/jbc.m502413200
- Kitajima, Y., Takasaki, Y., Takahashi, I. & Hori, K. Construction and properties of active chimeric enzymes between human aldolases A and B. Analysis of molecular regions which determine isozyme-specific functions. J. Biol. Chem. 265, 17493–17498 (1990). · doi:10.1016/s0021-9258(18)38191-2
- Morris, A. J. & Tolan, D. R. Lysine-146 of rabbit muscle aldolase is essential for cleavage and condensation of the C3-C4 bond of fructose 1,6-bisphosphate. Biochemistry 33, 12291–12297 (1994). · DOI
- Morris, A. J., Davenport, R. C. & Tolan, D. R. A lysine to arginine substitution at position 146 of rabbit aldolase A changes the rate-determining step to Schiff base formation. Protein Eng. 9, 61–67 (1996). · doi:10.1093/protein/9.1.61
- Blonski, C., De Moissac, D., Perie, J. & Sygusch, J. Inhibition of rabbit muscle aldolase by phosphorylated aromatic compounds. Biochemical J. 323, 71–77 (1997). · doi:10.1042/bj3230071
- Maurady, A., Zdanov, A., de Moissac, D., Beaudry, D. & Sygusch, J. A conserved glutamate residue exhibits multifunctional catalytic roles in d-fructose-1,6-bisphosphate aldolases. J. Biol. Chem. 277, 9474–9483 (2002). · doi:10.1074/jbc.m107600200
- Cousin, M. A. & Nicholls, D. G. Synaptic vesicle recycling in cultured cerebellar granule cells: role of vesicular acidification and refilling. J. Neurochem. 69, 1927–1935 (1997). · DOI
- Woods, A. et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21–33 (2005). · DOI · Paper page
- Shestov, A. A. et al. Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step. Elife https://doi.org/10.7554/eLife.03342 (2014). · DOI · Paper page
- Li, M. et al. Aldolase is a sensor for both low and high glucose, linking to AMPK and mTORC1. Cell Res. https://doi.org/10.1038/s41422-020-00456-8 (2020). · DOI
- Marsin, A. S. et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10, 1247–1255 (2000). · DOI · Paper page
- Markmann, S. et al. Quantitative proteome analysis of mouse liver lysosomes provides evidence for mannose 6-phosphate-independent targeting mechanisms of acid hydrolases in mucolipidosis II. Mol. Cell Proteomics 16, 438–450 (2017). · DOI · Paper page
- Leighton, F. et al. The large-scale separation of peroxisomes, mitochondria and lysosomes from the livers of rats injected with triton WR-1339. Improved isolation procedures, automated analysis, biochemical and morphological properties of fractions. J. Cell Biol. 37, 482–513 (1968). · DOI · Paper page
- Koivusalo, M., Steinberg, B. E., Mason, D. & Grinstein, S. In situ measurement of the electrical potential across the lysosomal membrane using FRET. Traffic 12, 972–982 (2011). · DOI
- Cokorinos, E. C. et al. Activation of skeletal muscle AMPK promotes glucose disposal and glucose lowering in non-human primates and mice. Cell Metab. 25, 1147–1159 (2017). · DOI · Paper page
- Steneberg, P. et al. PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients. JCI Insight https://doi.org/10.1172/jci.insight.99114 (2018). · DOI · Paper page
- Woods, A. et al. Liver-specific activation of AMPK prevents steatosis on a high-fructose diet. Cell Rep. 18, 3043–3051 (2017). · DOI · Paper page
- Boudaba, N. et al. AMPK reactivation suppresses hepatic steatosis but its downregulation does not promote fatty liver development. EBioMedicine 28, 194–209 (2018). · DOI · Paper page
- Garcia, D. et al. Genetic liver-specific AMPK activation protects against diet-induced obesity and NAFLD. Cell Rep. 26, 192–208 (2019). · DOI · Paper page
- Sakers, A., De Siqueira, M. K., Seale, P. & Villanueva, C. J. Adipose-tissue plasticity in health and disease. Cell 185, 419–446 (2022). · DOI · Paper page
- Zhao, P. et al. An AMPK–caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science 367, 652–660 (2020). · DOI · Paper page
- Song, L. et al. FGF4 protects the liver from non-alcoholic fatty liver disease by activating the AMPK–caspase 6 signal axis. Hepatology https://doi.org/10.1002/hep.32404 (2022). · DOI
- Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313–1321 (2005). · DOI · Paper page
- Bagherniya, M., Butler, A. E., Barreto, G. E. & Sahebkar, A. The effect of fasting or calorie restriction on autophagy induction: a review of the literature. Ageing Res. Rev. 47, 183–197 (2018). · DOI · Paper page
- Nakamura, N., Matsuura, A., Wada, Y. & Ohsumi, Y. Acidification of vacuoles is required for autophagic degradation in the yeast, Saccharomyces cerevisiae. J. Biochem. 121, 338–344 (1997). · DOI · Paper page
- Salt, I. P. & Hardie, D. G. AMP-activated protein kinase: an ubiquitous signaling pathway with key roles in the cardiovascular system. Circ. Res. 120, 1825–1841 (2017). · DOI · Paper page
- Arad, M., Seidman, C. E. & Seidman, J. G. AMP-activated protein kinase in the heart: role during health and disease. Circ. Res. 100, 474–488 (2007). · DOI · Paper page
- Yavari, A. et al. Chronic activation of γ2 AMPK induces obesity and reduces beta cell function. Cell Metab. 23, 821–836 (2016). · DOI · Paper page
- Hawley, S. A. et al. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336, 918–922 (2012). · DOI · Paper page
- Goldfine, A. B. et al. The effects of salsalate on glycaemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152, 346–357 (2010). · DOI · Paper page
- Meex, R. C., Phielix, E., Moonen-Kornips, E., Schrauwen, P. & Hesselink, M. K. Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions. J. Clin. Endocrinol. Metab. 96, 1415–1423 (2011). · DOI
- Fouqueray, P. et al. Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: a phase 1b study. Cell Rep. Med. 2, 100474 (2021). · DOI
- Cusi, K. et al. Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Gastroenterol. Hepatol. 6, 889–902 (2021). · DOI · Paper page
- Hammerschmidt, P. et al. CerS6-derived sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity. Cell 177, 1536–1552 (2019). · DOI · Paper page
- Wang, F. et al. Saturated very-long-chain fatty acid configures glycosphingolipid for lysosome homeostasis in long-lived C. elegans. Nat. Commun. 12, 5073 (2021). · DOI
- Grandjean, G. et al. Definition of a novel feed-forward mechanism for glycolysis–HIF1α signaling in hypoxic tumors highlights aldolase A as a therapeutic target. Cancer Res. 76, 4259–4269 (2016). · DOI · Paper page
- Gizak, A. et al. Targeting a moonlighting function of aldolase induces apoptosis in cancer cells. Cell Death Dis. 10, 712 (2019). · DOI
- Bai, D. et al. ALDOA maintains NLRP3 inflammasome activation by controlling AMPK activation. Autophagy https://doi.org/10.1080/15548627.2021.1997051 (2021). · DOI
- De Rosa, M. J. et al. The flight response impairs cytoprotective mechanisms by activating the insulin pathway. Nature 573, 135–138 (2019). · DOI
- Yuan, J. et al. Two conserved epigenetic regulators prevent healthy ageing. Nature 579, 118–122 (2020). · DOI
- Heron, P. W., Abellan-Flos, M., Salmon, L. & Sygusch, J. Bisphosphonate inhibitors of mammalian glycolytic aldolase. J. Med. Chem. 61, 10558–10572 (2018). · doi:10.1021/acs.jmedchem.8b01000
- Park, S. J. et al. DNA-PK promotes the mitochondrial, metabolic, and physical decline that occurs during aging. Cell Metab. 25, 1135–1146 (2017). · DOI · Paper page
- Luo, H. et al. AIDA selectively mediates downregulation of fat synthesis enzymes by ERAD to retard intestinal fat absorption and prevent obesity. Cell Metab. 27, 843–853 (2018). · DOI
- Hui, X. et al. Adipocyte SIRT1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue. EMBO Rep. 18, 645–657 (2017). · DOI · Paper page
- Zhang, M. et al. Loss of β-arrestin2 mediates pancreatic-islet dysfunction in mice. Biochem. Biophys. Res. Commun. 435, 345–349 (2013). · DOI
- Huang, D. et al. Intravital whole-process monitoring thermo-chemotherapy via 2D silicon nanoplatform: a macro guidance and long-term microscopic precise imaging strategy. Adv. Sci. 8, e2101242 (2021). · DOI
- Qiu, Q. et al. Noninvasive dual-modality photoacoustic-ultrasonic imaging to detect mammalian embryo abnormalities after prenatal exposure to methylmercury chloride (MMC): a mouse study. Environ. Health Perspect. 130, 27002 (2022). · DOI
- Liu, P. et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature 546, 107–112 (2017). · DOI · Paper page
- Chen, J. et al. Metformin extends C. elegans lifespan through lysosomal pathway. Elife https://doi.org/10.7554/eLife.31268 (2017). · DOI · Paper page
- Fang, E. F. et al. NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab. 24, 566–581 (2016). · DOI · Paper page
- Yen, K. et al. The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan. Aging 12, 11185–11199 (2020). · DOI · Paper page
- Rando, T. A. & Blau, H. M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. cell Biol. 125, 1275–1287 (1994). · DOI · Paper page
- Nargund, A. M., Fiorese, C. J., Pellegrino, M. W., Deng, P. & Haynes, C. M. Mitochondrial and nuclear accumulation of the transcription factor ATFS-1 promotes OXPHOS recovery during the UPR(mt). Mol. cell 58, 123–133 (2015). · DOI · Paper page
- Zhang, Q. et al. The memory of neuronal mitochondrial stress is inherited transgenerationally via elevated mitochondrial DNA levels. Nat. Cell Biol. 23, 870–880 (2021). · DOI
- Quiros, P. M., Goyal, A., Jha, P. & Auwerx, J. Analysis of mtDNA/nDNA ratio in mice. Curr. Protoc. Mouse Biol. 7, 47–54 (2017). · DOI · Paper page
- Ye, D. et al. Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil–macrophage crosstalk via the induction of CXCR2. J. Hepatol. 65, 988–997 (2016). · DOI · Paper page
- Mair, F. et al. Extricating human tumour immune alterations from tissue inflammation. Nature 605, 728–735 (2022). · DOI
- Mair, F. & Tyznik, A. J. High-dimensional immunophenotyping with fluorescence-based cytometry: a practical guidebook. Methods Mol. Biol. 2032, 1–29 (2019). · DOI
- Liechti, T. et al. An updated guide for the perplexed: cytometry in the high-dimensional era. Nat. Immunol. 22, 1190–1197 (2021). · DOI
- Preez, G. D. et al. Oxygen consumption rate of Caenorhabditis elegans as a high-throughput endpoint of toxicity testing using the Seahorse XFe96 Extracellular Flux Analyzer. Sci. Rep. 10, 4239 (2020). · DOI
- Kuznetsov, A. V. et al. Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat. Protoc. 3, 965–976 (2008). · DOI · Paper page
- Kobayashi, T. et al. Separation and characterization of late endosomal membrane domains. J. Biol. Chem. 277, 32157–32164 (2002). · DOI · Paper page
- Penhoet, E. E. & Rutter, W. J. Detection and isolation of mammalian fructose-diphosphate aldolases. Methods Enzymol. 42, 240–249 (1975). · DOI
- Choi, K. H. et al. Structure of a fructose-1,6-bis(phosphate) aldolase liganded to its natural substrate in a cleavage-defective mutant at 2.3 Å. Biochemistry 38, 12655–12664 (1999). · doi:10.1021/bi9828371
- Say, R. F. & Fuchs, G. Fructose 1,6-bisphosphate aldolase/phosphatase may be an ancestral gluconeogenic enzyme. Nature 464, 1077–1081 (2010). · DOI · Paper page
- Hu, H. et al. Phosphoinositide 3-kinase regulates glycolysis through mobilization of aldolase from the actin cytoskeleton. Cell 164, 433–446 (2016). · DOI · Paper page
- Bajad, S. U. et al. Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry. J. Chromatogr. A 1125, 76–88 (2006). · DOI · Paper page
- Hui, S. et al. Quantitative fluxomics of circulating metabolites. Cell Metab. 32, 676–688 (2020). · DOI · Paper page
- Choi, K. H., Shi, J., Hopkins, C. E., Tolan, D. R. & Allen, K. N. Snapshots of catalysis: the structure of fructose-1,6-(bis)phosphate aldolase covalently bound to the substrate dihydroxyacetone phosphate. Biochemistry 40, 13868–13875 (2001). · doi:10.1021/bi0114877
- Ma, J. et al. iProX: an integrated proteome resource. Nucleic Acids Res. 47, D1211–D1217 (2019). · DOI · Paper page
Cited by
Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology
Settembre, C., & Perera, R. M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00676-x · Cited by 285
SIRT2 regulates extracellular vesicle-mediated liver-bone communication
Lin, L., Guo, Z., He, E., Long, X., Wang, D., Zhang, Y., Guo, W., Wei, Q., He, W., Wu, W., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00803-0 · Cited by 88
Self-citationTargeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S. (2023) · MedComm · doi:10.1002/mco2.288 · Cited by 62
Fan, X., Jiao, G., Pang, T., Wen, T., He, Z., Han, J., Zhang, F., & Chen, W. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154740 · Cited by 50
Metadata
- Authors
- Zhang, C.-S., Li, M., Wang, Y., Li, X., Zong, Y., Long, S., Zhang, M., Feng, J.-W., Wei, X., Liu, Y.-H., Zhang, B., Wu, J., Zhang, C., Lian, W., Ma, T., Tian, X., Qu, Q., Yu, Y., Xiong, J., Liu, D.-T., Wu, Z., Zhu, M., Xie, C., Wu, Y., Xu, Z., Yang, C., Chen, J., Huang, G., He, Q., Huang, X., Zhang, L., Sun, X., Liu, Q., Ghafoor, A., Gui, F., Zheng, K., Wang, W., Wang, Z.-C., Yu, Y., Zhao, Q., Lin, S.-Y., Wang, Z.-X., Piao, H.-L., Deng, X., & Lin, S.-C.
- Venue
- Nature Metabolism
- Published
- 2022-10-10
- Volume
- 4
- Issue
- 10
- Pages
- 1369-1401
- ISSN
- 2522-5812 (ISSN-L)
- OpenAlex
- W4304080692
- Cited by
- 99
- References
- 43
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Ministry of Education of the People’s Republic of China (#BP2018017)
- Xiamen University (#20720200069, 2020Y1021, #20720190084)
- National Natural Science Foundation of China (#82088102, #91854208, #92157001, #31922034, #92057204, #32070753, #22025702, #82021003, #82151211, #91853203)
- Ministry of Science and Technology of the People’s Republic of China (2020YFA0803402, 2017YFA0504504)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. https://app.cochat.ai/papers/10.1038/s42255-022-00640-7
- The paper
- Zhang, C.-S., Li, M., Wang, Y., Li, X., Zong, Y., Long, S., Zhang, M., Feng, J.-W., Wei, X., Liu, Y.-H., Zhang, B., Wu, J., Zhang, C., Lian, W., Ma, T., Tian, X., Qu, Q., Yu, Y., Xiong, J., . . . Lin, S.-C. (2022). The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. Nature Metabolism. https://doi.org/10.1038/s42255-022-00640-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.